[1] DeSantis CE, Ma J, Goding Sauer A, Newman LA and Jemal A. Breast cancer statistics, 2017, racial disparity in mortality by state. CA. Cancer J. Clin. (2017) 67: 439-48.
[2] Tagne SR, Armel HNK and Farah M. Medicinal Plants in Breast Cancer Therapy. J. Dis. Med. Plants (2015) 1: 19-23.
[3] Ma H, Carpenter CL, Sullivan-Halley J and Bernstein L. The roles of herbal remedies in survival and quality of life among long-term breast cancer survivors-results of a prospective study. BMC Cancer (2011) 11: 222-31.
[4] Sadeghi M, Zolfaghari B, Senatore M and Lanzotti V. Antifungal cinnamic acid derivatives from Persian leek (Allium ampeloprasum subsp. persicum). Phytochem. Lett. (2013) 6: 360-3.
[5] Park JB and Schoene N. N-Caffeoyl tyramine arrests growth of U937 and Jurkat cells by inhibiting protein tyrosine phosphorylation and inducing caspase-3. Cancer Lett. (2003) 202: 161-71.
[6] Kunduzova OR, Bianchi P, Pizzinat N, Escourrou G, Seguelas MH, Parini A and Cambon C. Regulation of JNK/ERK activation, cell apoptosis, and tissue regeneration by monoamine oxidases after renal ischemia-reperfusion. FASEB J. (2002) 16: 1129-31.
[7] Blake RA, Broome MA, Liu X, Wu J, Gishizky M, Sun L and Courtneidge SA. SU6656, a selective src family kinase inhibitor, used to probe growth factor signaling. Mol. Cell. Biol. (2000) 20: 9018-27.
[8] Subik K, Lee JF, Baxter L, Strzepek T, Costello D, Crowley P, Xing L, Hung MC, Bonfiglio T, Hicks DG and Tang P. The expression patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by immunohistochemical analysis in breast cancer cell lines. Breast Cancer (2010) 4: 35-41.
[9] Manasa J, Musabaike H, Masimirembwa C, Burke E, Luthy R and Mudzori J. Evaluation of the Partec flow cytometer against the BD FACSCalibur system for monitoring immune responses of human immunodeficiency virus-infected patients in Zimbabwe. Clin. Vaccine Immunol. (2007) 14: 293-8.
[10] Hadjipavlou-Litina D and Pontiki E. Aryl-acetic and cinnamic acids as lipoxygenase inhibitors with antioxidant, anti-inflammatory, and anticancer activity. Advanced protocols in oxidative stress III, Humana Press, New York (2015) 361-377.
[11] De P, Baltas M and Bedos-Belval F. Cinnamic acid derivatives as anticancer agents-a review. Curr. Med. Chem. (2011) 18: 1672-703.
[12] Ekmekcioglu C, Feyertag J and Marktl W. Cinnamic acid inhibits proliferation and modulates brush border membrane enzyme activities in Caco-2
cells. Cancer Lett. (1998) 128: 137-44.
[13] Pontiki E, Hadjipavlou-Litina D, Litinas K and Geromichalos G. Novel cinnamic acid derivatives as antioxidant and anticancer agents: Design, synthesis and modeling studies. Molecules (2014) 19: 9655-74.
[14] Lee DG, Park Y, Kim MR, Jung HJ, Seu YB, Hahm KS and Woo ER. Anti-fungal effects of phenolic amides isolated from the root bark of Lycium chinense. Biotechnol. Lett. (2004) 26: 1125-30.
[15] De Oliveira Niero EL and Machado-Santelli GM. Cinnamic acid induces apoptotic cell death and cytoskeleton disruption in human melanoma cells. J. Exp. Clin. Cancer Res. (2013) 32: 31-44.